Determining the Effect of an "Alternate Recovery Protocol" Versus Current Standard of Care After Cesarean Section
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03330119|
Recruitment Status : Terminated (Lack of Funding/ Resident in charge graduated)
First Posted : November 6, 2017
Last Update Posted : August 14, 2018
This randomized controlled trial will compare two different approaches to patient recovery after cesarean section: the current standard of care versus an alternate management protocol. The goal of this study is to investigate whether an "alternate management" protocol after cesarean sections will yield the same results as alternate management in other surgical fields, including decreased narcotic consumption and quicker return of bowel function, without compromising patient morbidity or satisfaction.
The investigators will assess postoperative narcotic consumption as the primary outcome. Secondary outcomes will be return of bowel function, length of hospital stay, pain control, patient satisfaction, post-operative complications, and overall morbidity and mortality.
Hypothesis: Initiating the alternate management protocol for cesarean sections will decrease narcotic consumption and hasten return of bowel function, without compromising patient satisfaction, level of pain control, or post-operative morbidity.
|Condition or disease||Intervention/treatment||Phase|
|Pregnancy Related Narcotic Use||Drug: Alternate Management Drug: Control||Phase 3|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||7 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Determining the Effect of an "Alternate Recovery Protocol" Versus Current Standard of Care After Cesarean Section|
|Actual Study Start Date :||October 4, 2017|
|Actual Primary Completion Date :||June 20, 2018|
|Actual Study Completion Date :||June 20, 2018|
|Experimental: Alternate Management||
Drug: Alternate Management
With the alternate management protocol, the pre-operative order set is the same, with the addition of a single preoperative dose of acetaminophen 1 g IV x1, gabapentin 600 mg PO x1, and ondansetron 8 mg IV x1. Post-operatively, patients receive the same ketorolac 30mg x 9 doses every 6 hours, as well as acetaminophen 975 mg every 6 hours, both given standing. These two are timed so the patient is receiving one of the two medications every 3 hours during their inpatient stay. After 9 doses of ketorolac, the patient receives 600mg of ibuprofen PO, also given standing, instead of the ketorolac. If the patient requires narcotics, they may receive them on an as needed basis. IV fluids are running at 80 cc/ hour. Patients are encouraged to ambulate, including the evening of the surgery, have their foley catheter removed 12 hours post-operatively, and can have a regular diet immediately.
Other Name: Enhanced Recovery
Placebo Comparator: Control
The regular Lankenau cesarean section order set.
The regular Lankenau cesarean section order set includes routine vital signs, labs, IV fluids, and fetal heart monitoring. Post standard cesarean section orders include IV fluids running at 125 cc/ hour, along with routine post-partum care. In terms of pain control, most patients receive 9 doses of 30mg of IV ketorolac every 6 hours, along with hydromorphone, oxycodone/acetaminophen, or a hydromorphone PCA, per patient or attending request.
- Narcotic utilization [ Time Frame: From time of consent until hospital discharge (3 days) ]
total narcotic utilization measured with Morphine Equivalent Score
The conversion scale being used will be the Center for Disease Control and Prevention Morphine Equivalent Score. https://www.cdc.gov/drugoverdose/pdf/calculating_total_daily_dose-a.pdf
Lower scores represent less opioid use and a better outcome. Higher scores represent more opioid use and a worse outcome.
- Flatus [ Time Frame: From time of consent until hospital discharge (3 days) ]First return to bowel function
- Pain [ Time Frame: From time of consent until hospital discharge (3 days) ]Pain via a postoperative pain scale. This is a visual analog scale from 0 to 100. The patient will select a point on the scale indicating the level of pain they are feeling or felt in the indicated period. The number 0 indicates no pain, and 100 indicates the worst pain possible and felt in the period.
- Patient Satisfaction [ Time Frame: From time of consent until hospital discharge (3 days) ]Patient satisfaction will be assessed using the validated survey used in the Mayo Clinic Trial
- Postoperative complications during inpatient stay [ Time Frame: From time of consent until hospital discharge (3 days) ]
- Length of Stay [ Time Frame: Up to 3 days ]From time of consent until hospital discharge
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03330119
|United States, Pennsylvania|
|Lankenau Medical Center|
|Wynnewood, Pennsylvania, United States, 19096|
|Principal Investigator:||Norman Brest, MD|